Latest Insider Transactions at Athenex, Inc. (ATNX)
This section provides a real-time view of insider transactions for Athenex, Inc. (ATNX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Athenex, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Athenex, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 29
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
22,485
+0.64%
|
$0
$0.51 P/Share
|
|
Jul 20
2022
|
Jinn Wu Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,772
+2.66%
|
$0
$0.67 P/Share
|
|
Jul 20
2022
|
John Vierling Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,772
+31.46%
|
$0
$0.67 P/Share
|
|
Jul 20
2022
|
Robert J. Spiegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,508
+34.66%
|
$0
$0.67 P/Share
|
|
Jul 20
2022
|
Manson Fok Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,270
+0.55%
|
$0
$0.67 P/Share
|
|
Jul 20
2022
|
Stephanie A Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,138
+17.58%
|
$0
$0.67 P/Share
|
|
Jul 20
2022
|
Benson Kwan Hung Tsang Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,280
+28.87%
|
$0
$0.67 P/Share
|
|
Jul 15
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
843
+9.39%
|
$0
$0.59 P/Share
|
|
Jul 15
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,256
+2.99%
|
$0
$0.59 P/Share
|
|
Jul 15
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
19,208
+0.55%
|
$0
$0.59 P/Share
|
|
Jul 09
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,665
+3.36%
|
$0
$0.51 P/Share
|
|
Jul 01
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,154
+13.67%
|
$0
$0.43 P/Share
|
|
Jul 01
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,316
+4.17%
|
$0
$0.43 P/Share
|
|
Jul 01
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
26,328
+0.76%
|
$0
$0.43 P/Share
|
|
Jun 17
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
23,356
+0.68%
|
$0
$0.49 P/Share
|
|
Jun 17
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,832
+9.08%
|
$0
$0.49 P/Share
|
|
Jun 17
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,025
+14.31%
|
$0
$0.49 P/Share
|
|
Jun 03
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
23,095
+0.68%
|
$0
$0.49 P/Share
|
|
Jun 03
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,927
+4.25%
|
$0
$0.49 P/Share
|
|
Jun 03
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,013
+16.54%
|
$0
$0.49 P/Share
|
|
May 20
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
23,583
+0.7%
|
$0
$0.48 P/Share
|
|
May 20
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,137
+4.53%
|
$0
$0.48 P/Share
|
|
May 20
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,034
+20.15%
|
$0
$0.48 P/Share
|
|
May 06
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
23,516
+0.7%
|
$0
$0.05 P/Share
|
|
May 06
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,107
+4.73%
|
$0
$0.48 P/Share
|
|
May 06
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,031
+25.18%
|
$0
$0.48 P/Share
|
|
Apr 22
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
18,578
+0.56%
|
$0
$0.61 P/Share
|
|
Apr 22
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,986
+3.96%
|
$0
$0.61 P/Share
|
|
Apr 22
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
815
+28.62%
|
$0
$0.61 P/Share
|
|
Apr 08
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
665
+35.32%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
15,160
+0.46%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
Stephanie A Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,316
+19.36%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
Manson Fok Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,973
+0.49%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,516
+3.39%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
Robert J. Spiegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,989
+50.0%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
Benson Kwan Hung Tsang Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,292
+37.68%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
John Vierling Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,303
+42.89%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
Jinn Wu Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,303
+2.43%
|
$0
$0.75 P/Share
|
|
Mar 25
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,422
+2.94%
|
$0
$0.9 P/Share
|
|
Mar 25
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
553
+50.0%
|
$0
$0.9 P/Share
|
|
Mar 25
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
12,613
+0.38%
|
$0
$0.9 P/Share
|
|
Nov 22
2021
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
3,000
+0.09%
|
$3,000
$1.84 P/Share
|
|
Nov 18
2021
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
3,000
+0.09%
|
$3,000
$1.87 P/Share
|
|
Nov 17
2021
|
Jordan Kanfer Director |
BUY
Open market or private purchase
|
Direct |
4,952
+34.06%
|
$9,904
$2.02 P/Share
|
|
Nov 17
2021
|
Jinn Wu Director |
BUY
Open market or private purchase
|
Direct |
30,000
+3.31%
|
$60,000
$2.04 P/Share
|
|
Nov 16
2021
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+2.25%
|
$8,000
$2.05 P/Share
|
|
Nov 16
2021
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
3,000
+0.09%
|
$6,000
$2.06 P/Share
|
|
Nov 15
2021
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
5,000
+0.15%
|
$10,000
$2.12 P/Share
|
|
Nov 12
2021
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
10,000
+0.31%
|
$20,000
$2.07 P/Share
|
|
Oct 01
2021
|
Jinn Wu Director |
BUY
Open market or private purchase
|
Direct |
10,000
+2.36%
|
$20,000
$2.67 P/Share
|